Evidence map›Paper›PMID 30392423›Full record

ArticlePharmaceutical biology2018

Phylogenetic analysis of Uncaria species based on internal transcribed spacer (ITS) region and ITS2 secondary structure.

Shuang Zhu, Qiwei Li, Shanchong Chen, Yesheng Wang, Lin Zhou, Changqing Zeng, Jun Dong

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Investigating Potential Inhibitory Effect ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shuang Zhua Center for Bioresources and Drug Discovery and School of Biosciences and Biopharmaceutics Guangdong Province Key Laboratory for Biotechnology Drug Candidates , Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.
Qiwei Lia Center for Bioresources and Drug Discovery and School of Biosciences and Biopharmaceutics Guangdong Province Key Laboratory for Biotechnology Drug Candidates , Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.ORCID http://orcid.org/0000-0002-7674-5565
Shanchong Chena Center for Bioresources and Drug Discovery and School of Biosciences and Biopharmaceutics Guangdong Province Key Laboratory for Biotechnology Drug Candidates , Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.
Yesheng Wanga Center for Bioresources and Drug Discovery and School of Biosciences and Biopharmaceutics Guangdong Province Key Laboratory for Biotechnology Drug Candidates , Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.
Lin Zhoua Center for Bioresources and Drug Discovery and School of Biosciences and Biopharmaceutics Guangdong Province Key Laboratory for Biotechnology Drug Candidates , Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.
Changqing Zengb School of Traditional Chinese Medicine , Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.
Jun Dongb School of Traditional Chinese Medicine , Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.
Guangdong Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe plant genus Uncaria (Rubiaceae), also known as Gouteng, is the source of an important traditional Chinese medicine. Misidentification and adulteration of Gouteng affect the safety and efficacy of the medication. Phylogenetic relationships among the species of this genus are unknown.

objectiveThe present study sought to detect the phylogenetic relationships based on internal transcribed spacer (ITS) region of all 12 species of Uncaria recorded in the Flora of China. MATERIALS AND

methodsAccession of seven species of Uncaria served as reference samples. ITS region was used for polymerase chain reaction (PCR) amplification of the reference samples representing 39 specimens. Distance analysis, species discrimination, and secondary structure of ITS2 were used to assess the ability of ITS sequence in authenticating. The phylogenetic relationships were detected using three methods: Bayesian inference (BI), maximum likelihood (ML), and neighbor joining (NJ).

resultsFive species of traditional Chinese medicine Gouteng were well resolved in molecular phylogenetic tree. Besides, Uncaria lancifolia Hutch. was closer to U. rhynchophylloides F.C. How and U. sessilifructus Roxb. was closer to U. laevigata Wall. within the tree. Further, we also found that ITS2 secondary structure can be a candidate tool in distinguishing two closely related species U. yunnanensis K.C.Hsia and U. lanosa Wall. For accurate identification of different species of Uncaria based on species-specific nucleotide sites, a consensus sequences database with all 12 species is established. DISCUSSIONS AND

conclusionsThe results are able to discriminate Uncaria species and illustrate the phylogenetic relationships, which are essential for the investigation of adulterants and misidentifications of Uncaria.

Indexed as

Genes, rRNADNA Barcoding, TaxonomicDNA, PlantDNA, Ribosomal SpacerNucleic Acid ConformationPhylogenyPlants, MedicinalPolymerase Chain ReactionUncariaDNA, PlantDNA, Ribosomal SpacerdiscriminationDNA barcodingMolecular phylogeny

Identifiers

PMID30392423
PMCPMC6225500
OpenAlexW2898822802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.